Unrelated donor bone marrow transplantation with treosulfan-based myeloablative conditioning for paroxysmal nocturnal hemoglobinuria - Successful treatment despite multiple transplant-related risk factors for hemolysis including major Kidd group incompatibility [2]

Bone Marrow Transplantation

Volumn 37, Issue 2, 2006, Pages 231-232

  Markiewicz, Mir ^a   Wojciechowska, M ^a   Wylezol I ^a   Wozniczka K ^a   Giebel, S ^a   Wojnar, J ^a   Krawczyk Kulis M ^a   Mendek Czajkowska, E ^b   Holowiecki J ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DECAY ACCELERATING FACTOR; ENOXAPARIN; FLUDARABINE; FOLIC ACID; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN; IRON; LOW MOLECULAR WEIGHT HEPARIN; METHOTREXATE; METHYLPREDNISOLONE; NADROPARIN; PREDNISONE; THYMOCYTE ANTIBODY; TREOSULFAN;

ADULT; AGRANULOCYTOSIS; ALLOGENIC BONE MARROW TRANSPLANTATION; BLOOD GROUP KIDD SYSTEM; CASE REPORT; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; FLOW CYTOMETRY; FOLIC ACID DEFICIENCY; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMOLYSIS; HUMAN; IMMUNOGLOBULIN DEFICIENCY; IRON DEFICIENCY; LABORATORY TEST; LETTER; MALE; NAUSEA; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VEIN THROMBOSIS; VIRUS REACTIVATION;

ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; BLOOD GROUP INCOMPATIBILITY; BONE MARROW TRANSPLANTATION; BUSULFAN; HEMOGLOBINURIA, PAROXYSMAL; HEMOLYSIS; HISTOCOMPATIBILITY; HUMANS; KIDD BLOOD-GROUP SYSTEM; LIVING DONORS; MALE; RISK FACTORS; TRANSPLANTATION CONDITIONING;

EID: 30944449849     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705210     Document Type: Letter

References (9)

1. Saso R, Marsh J, Cevreska L, Szer J, Gale RP, Rowlings PA et al. Bone marrow transplants for paroxysmal nocturnal haemoglobinuria. Br J Haematol 1999; 104: 392-396.
2. Woodard P, Wang W, Pitts N, Benaim E, Horwitz E, Cunningham J et al. Successful unrelated donor bone marrow transplantation for paroxysmal nocturnal hemoglobinuria. Bone Marrow Transplant 2001; 27: 589-592.
3. Flotho C, Strahm B, Kontny U, Duffner U, Peters AM, Dupuis W et al. Stem cell transplantation for paroxysmal nocturnal haemoglobinuria in childhood. Br J Haematol 2002; 118: 124-127.
4. Lee JL, Lee JH, Lee JH, Choi SJ, Kim S, Seol M et al. Allogeneic hematopoietic cell transplantation for paroxysmal nocturnal hemoglobinuria. Eur J Haematol 2003; 71: 114-118.
5. Hegenbart U, Niederwieser D, Forman S, Holler E, Leiblein S, Johnston L et al. Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria. Biol Blood Marrow Transplant 2003; 9: 689-697.
6. Jochen C, Blau W, Volin L, Ruutu T, Wandt H, Schaefer-Eckart K et al. Allogeneic haematopoietic stem cell transplantation after treosulfan/ fludarabine conditioning in high-risk patients with hematologic malignancies. Dose escalation of treosulfan. Blood 2003; 102: 467a (abstract 1704).
7. Grosskreutz C, Ross V, Scigliano E, Fruchtman S, Isola L. Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation. Biol Blood Marrow Transplant 2003; 9: 453-459.
8. Takahashi Y, McCoy JPJr, Carvallo C, Rivera C, Igarashi T, Srinivasan R et al. In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation. Blood 2004; 103: 1383-1390.
9. Chakrabarti S, Takahashi Y, Srinivasan R, Espinoza I, Igarashi T, Suffredini D et al. Durable engraftment and long-tern survival following fludarabine-based nonmyeloablative hematopoietic cell transplantation (HCT) in patients with ATG-refractory severe aplastic anemia (SAA) and other nonmalignant hematological disorders. Blood 2004; 104: 252.